OA 中文
R & D
R
&
D

General Information on R&D

General Information on R&D

I: R&D Team

The team is formed of senior researchers who have rich experience in the R&D of biological products in China. Meanwhile, top scientists in the field from all over the world are invited as consultants to provide technical support and guidance for the establishment and implementation of R&D projects.

II: Vaccine R&D Pilot Platform

The Vaccine R&D Pilot Platform is designed and built in compliance with Chinese GMP 2010. The sterile workshop is about 1000m2, which is available for strain preparation; cell culture; bacterial fermentation; product purification; formulation preparation; sub-packaging and lyophilizing.


Product Pipeline

Research and innovation is the vital force of an enterprise. Olymvax adopts the “independent and cooperative research” as its R&D model. Through years of hard work, Olymvax has formed a stair-like product development process, where there are multiple products across many stages of development, 2 vaccine products are already launched on the market; several products have entered clinical trials and numerous products are moving through the pipeline at a stable pace.


  • Preclinical Study
    Preclinical Study
    Clinical Registration
    Clinical Registration
    Clinical Trial
    Clinical Trial
    Production Registration
    Production Registration